TScan Therapeutics, Inc (TCRX) Price 6.7M Share IPO at $15/sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- US stocks set for lower open as Iran stalemate lifts oil, yields
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Trump threatens to bomb Oman over Iran stance
- Goldman Sachs to acquire real estate company LCN for up to $410M
TScan Therapeutics, Inc (TCRX) IPO Opens 20% Lower
July 16, 2021 11:38 AM EDTToday's IPO for TScan Therapeutics, Inc (NYSE: TCRX) opened for trading at $12 after pricing 6,666,667 shares of common stock at a public offering price of $15.00 per share.
Morgan Stanley, Jefferies, Cowen and Barclays are acting as Joint Book-running Managers for the offering.
TScan is... More
